Ahs Cancer Control Alberta
Clinical trials sponsored by Ahs Cancer Control Alberta, explained in plain language.
-
Gentler brain cancer treatment tested for frail elderly
Disease control Recruiting nowThis study is testing whether chemotherapy alone works as well as the standard combination of chemotherapy plus radiation for elderly and frail patients with newly diagnosed glioblastoma, an aggressive brain cancer. Researchers want to see if skipping radiation reduces side effec…
Phase: PHASE2 • Sponsor: AHS Cancer Control Alberta • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Asthma inhaler tested to tame dangerous side effect of cancer treatment
Disease control Recruiting nowThis study is testing if using an inhaled steroid (like those for asthma) for one year can help prevent lung inflammation from coming back in cancer patients. The inflammation is a serious side effect of powerful immunotherapy drugs. The goal is to control this side effect with f…
Phase: PHASE2 • Sponsor: AHS Cancer Control Alberta • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
Cancer patients could skip hospital trips: home chemo trial underway
Disease control Recruiting nowThis study is testing whether patients with multiple myeloma can safely give themselves their standard chemotherapy injections at home instead of traveling to a hospital. Researchers want to see if home administration works well, is safe, and improves quality of life for patients…
Phase: PHASE2 • Sponsor: AHS Cancer Control Alberta • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
Could skipping groin radiation reduce harsh side effects for anal cancer patients?
Disease control Recruiting nowThis study is testing a new approach for treating early-stage anal cancer. It aims to see if carefully selected patients can safely avoid receiving preventative radiation to their groin area, which is part of standard treatment. The goal is to see if this approach is just as effe…
Phase: PHASE2 • Sponsor: AHS Cancer Control Alberta • Aim: Disease control
Last updated Mar 12, 2026 13:52 UTC
-
Can we skip steroids? new strategy tests monitoring for cancer treatment liver side effects
Disease control Recruiting nowThis study aims to find out if close monitoring works as well as immediate steroid treatment for liver inflammation caused by cancer immunotherapy drugs. It will enroll 56 cancer patients who develop this specific side effect. Participants will be randomly assigned to either rece…
Phase: NA • Sponsor: AHS Cancer Control Alberta • Aim: Disease control
Last updated Feb 27, 2026 15:17 UTC
-
Allergy pill may ease agonizing bone pain for cancer patients
Symptom relief Recruiting nowThis study is testing whether the common allergy medication loratadine can prevent or reduce severe bone pain caused by drugs used to prepare for stem cell transplants. The trial involves 78 adults with lymphoma or multiple myeloma who are scheduled for stem cell transplants. Par…
Phase: PHASE2 • Sponsor: AHS Cancer Control Alberta • Aim: Symptom relief
Last updated Mar 31, 2026 12:11 UTC
-
New combo therapy aims to help advanced cancer patients swallow again
Symptom relief Recruiting nowThis study is testing if adding two chemotherapy drugs to a short course of radiation therapy works better than radiation alone to relieve severe swallowing problems in people with advanced, inoperable esophageal cancer. It will involve about 50 patients and focuses on improving …
Phase: PHASE2 • Sponsor: AHS Cancer Control Alberta • Aim: Symptom relief
Last updated Mar 20, 2026 14:48 UTC